Trending...
- California: Governor Newsom, Superintendent Thurmond announce over $618 million to support another 458 community schools
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
WEST HOLLYWOOD, Calif. - Californer -- Simufilam is a leading candidate to become the first effective treatment for Alzheimer's Disease. In an analysis by sfbanc financial, Cassava Sciences, Inc. (SAVA) was upgraded as a Strong Buy, from 8/10 to 9.5/10.
The drug in development purportedly works by retiring the proper conformation of filamin A, a molecule involved in the cascade of Alzheimer's disease. Open-label results are showing effectiveness in 84% of subjects treated. These promising results, along with recent insider buying, has led the sfbanc community to upgrade the stock.
More on The Californer
Additional results from the open label trial are expected by the end of this year. Call volume shows optimism for the results of the Cognitive Maintenance Study (CMS) in late 2023. This trial will include 100 subjects randomized to switch from active drug to placebo. Simufilam is currently in two randomized placebo-controlled Phase 3 trials.
sfbanc is a financial community that provides analysis and discussion of available public information in the finance sector. https://sfbanc.com
The drug in development purportedly works by retiring the proper conformation of filamin A, a molecule involved in the cascade of Alzheimer's disease. Open-label results are showing effectiveness in 84% of subjects treated. These promising results, along with recent insider buying, has led the sfbanc community to upgrade the stock.
More on The Californer
- OGN INVESTIGATION NOTICE: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm
- San Diego Author Debuts Thrilling Time-Travel Novel
- Bennett Awards Designs Two Cohesive Custom Awards for 2025 Sci-Tech Academy Awards
- Poll Finds Overwhelming Opposition to Keeping Big Cats as Pets
- SM Telecom Expands AT&T Partnership to Deliver Cutting-Edge 5G+ Wireless Solutions New Collab Brings AT&T's Advanced 5G+ Technology to Cellphone
Additional results from the open label trial are expected by the end of this year. Call volume shows optimism for the results of the Cognitive Maintenance Study (CMS) in late 2023. This trial will include 100 subjects randomized to switch from active drug to placebo. Simufilam is currently in two randomized placebo-controlled Phase 3 trials.
sfbanc is a financial community that provides analysis and discussion of available public information in the finance sector. https://sfbanc.com
Source: sfbanc
1 Comment
- J Hautau:
SAVA🚀 no side effects. Promising.
Latest on The Californer
- Nicky Dare Honors Indonesian Heritage at VAPI–Valley Asian and Pacific Islanders Cultural Festival
- California launches new AI-powered chatbot that provides wildfire resources in 70 languages
- Summit Startup Solutions Launches Innovative, Flexible Support Services for Startups
- Cal Lutheran Celebrates 1,018 Graduates!
- California: Governor Newsom appointed co-chair of U.S. Climate Alliance
- Archer to Open Second Manufacturing Plant in Los Angeles to Meet Surging Demand for Meat Stick Business
- NeighborWorks America selects Cabrillo EDC CEO for NeighborWorks Achieving Excellence Program
- Fairmint Introduces First Fully Onchain and Open Cap Table Infrastructure
- Vortex Brands Begins Gold Purchases Under New Joint Venture with Dubai-Based Partner
- Porta Potty USA Expands its Convenient Portable Restroom Rental Services Business in Louisiana Area
- Miss United Crown of America Launches as a National Platform for Purpose-Driven Titleholders
- Judge Joscelyn Jones Honored with Toastmasters Award for Communication and Leadership Excellence
- California: Governor Newsom announces appointments 5.8.25
- Long Beach Parks, Recreation and Marine and Fire Department to Host Water Safety Day
- Terra Divine Skincare Earns Coveted Spot on Organically Becca's Clean Brand Master List
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- Emmetra Partners with Renesas to Advance Agentic AI-Powered Imaging Solutions
- Gravity to Bring 5-Minute EV Charging to 8 Sites Across Greater LA
- California: Governor Newsom issues statement on Pope Leo XIV, the first American Pope
- New poll shows high rates of employee burnout amid concerns over politics and personal finances